Summary

Global Lymphedema Treatment Market is valued approximately USD XXXX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XXXX % over the forecast period 2021-2027. Lymphedema happens if the the lymph vessels is not able to adequately drain lymph fluid, it occurs commonly on arms and legs. The most common causes of lymphedema is Cancer. The treatment of the disease may include compression bandages, massage, compression stockings, sequential pneumatic pumping, careful skin care and, rarely, surgery to remove swollen tissue or to create new drainage routes. Increase in number of lymphedema cases globally is driving the growth for the market. For instance: according to NHS, about 200,000 suffer from lymphedema in U.K. annually. Also, increase in research and development investment for drug discovery and increasing health care expenditure is accelerating the market growth for lymphedema treatment. However, high costs of surgery impede the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global Lymphedema Treatment market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is to dominate the market lymphedema treatment market in the forecasted period. As there is increase in prevalence of breast cancer in the region. For instance, according to the Lymphatic Education & Research Network, approximately 10 million Americans suffer from lymphedema and lymphatic diseases. Whereas, Asia-Pacific is anticipated to exhibit highest CAGR over the forecast period 2021-2027. Because there is increase in incidence of breast cancer and growing patient awareness of the lymphedema treatment.

Major market player included in this report are:
PAUL HARTMANN AG
Convatec Inc.
SIGVARIS GROUP
Sanyleg Srl a socio unico
AIROS Medical, Inc.
Tactile Medical
BIOCOMPRESSION SYSTEMS
Lohmann & Rauscher GmbH & Co. KG
Mego Afek ltd.
ThermoTek, Cardinal Health

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment Type:
Compression Therapy
Surgery
Drug Therapy
Laser Therapy
Others
By Type:
Primary Lymphedema
Secondary Lymphedema
By Affected Area:
Genital
Lower Extremity
Upper Extremity
Others
By Age Group:
Adult
Geriatric
By Route of Administration:
Oral
Injectable
Others
By End User
Hospitals
Ambulatory Surgical Centers
Speciality Clinics
Others
By Distribution Channel:
Direct Tender
Pharmacy Stores
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Lymphedema Treatment Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors




Crash barrier systems
Lymphedema Treatment
Media Monitoring Tools
Automotive Connecting Rod Bearing

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Lymphedema Treatment Market, by Region, 2019-2027 (USD Billion)
1.2.2. Lymphedema Treatment Market, by Treatment Type, 2019-2027 (USD Billion)
1.2.3. Lymphedema Treatment Market, by Type, 2019-2027 (USD Billion)
1.2.4. Lymphedema Treatment Market, by Affected Area, 2019-2027 (USD Billion)
1.2.5. Lymphedema Treatment Market, by Age group, 2019-2027 (USD Billion)
1.2.6. Lymphedema Treatment Market, by Route of Administration, 2019-2027 (USD Billion)
1.2.7. Lymphedema Treatment Market, by End User, 2019-2027 (USD Billion)
1.2.8. Lymphedema Treatment Market, by Distribution Channel, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Lymphedema Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Lymphedema Treatment Market Dynamics
3.1. Lymphedema Treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing cases of lymphedema diseases
3.1.2. Market Challenges
3.1.2.1. High cost of Surgery
3.1.3. Market Opportunities
3.1.3.1. Increasing R&D for drugs
Chapter 4. Global Lymphedema Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Lymphedema Treatment Market, by Treatment Type
6.1. Market Snapshot
6.2. Global Lymphedema Treatment Market by Treatment Type, Performance - Potential Analysis
6.3. Global Lymphedema Treatment Market Estimates & Forecasts by Treatment Type 2018-2027 (USD Billion)
6.4. Lymphedema Treatment Market, Sub Segment Analysis
6.4.1. Compression Therapy
6.4.2. Surgery
6.4.3. Drug Therapy
6.4.4. Laser Therapy
6.4.5. Others
Chapter 7. Global Lymphedema Treatment Market, by Type
7.1. Market Snapshot
7.2. Global Lymphedema Treatment Market by Type, Performance - Potential Analysis
7.3. Global Lymphedema Treatment Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
7.4. Lymphedema Treatment Market, Sub Segment Analysis
7.4.1. Primary Lymphedema
7.4.2. Secondary Lymphedema
Chapter 8. Global Lymphedema Treatment Market, by Affected Area
8.1. Market Snapshot
8.2. Global Lymphedema Treatment Market by Affected Area, Performance - Potential Analysis
8.3. Global Lymphedema Treatment Market Estimates & Forecasts by Affected Area 2018-2027 (USD Billion)
8.4. Lymphedema Treatment Market, Sub Segment Analysis
8.4.1. Genital
8.4.2. Lower Extremity
8.4.3. Upper Extremity
8.4.4. Others
Chapter 9. Global Lymphedema Treatment Market, by Age Group
9.1. Market Snapshot
9.2. Global Lymphedema Treatment Market by Age Group, Performance - Potential Analysis
9.3. Global Lymphedema Treatment Market Estimates & Forecasts by Age Group 2018-2027 (USD Billion)
9.4. Lymphedema Treatment Market, Sub Segment Analysis
9.4.1. Adult
9.4.2. Geriatric
Chapter 10. Global Lymphedema Treatment Market, by Route of Administration
10.1. Market Snapshot
10.2. Global Lymphedema Treatment Market by Route of Administration, Performance - Potential Analysis
10.3. Global Lymphedema Treatment Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
10.4. Lymphedema Treatment Market, Sub Segment Analysis
10.4.1. Oral
10.4.2. Injectable
10.4.3. Others
Chapter 11. Global Lymphedema Treatment Market, by End User
11.1. Market Snapshot
11.2. Global Lymphedema Treatment Market by End User, Performance - Potential Analysis
11.3. Global Lymphedema Treatment Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
11.4. Lymphedema Treatment Market, Sub Segment Analysis
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Speciality Clinics
11.4.4. Others
Chapter 12. Global Lymphedema Treatment Market, by Distribution Channel
12.1. Market Snapshot
12.2. Global Lymphedema Treatment Market by Distribution Channel, Performance - Potential Analysis
12.3. Global Lymphedema Treatment Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)
12.4. Lymphedema Treatment Market, Sub Segment Analysis
12.4.1. Direct Tender
12.4.2. Pharmacy Stores
12.4.3. Others
Chapter 13. Global Lymphedema Treatment Market, Regional Analysis
13.1. Lymphedema Treatment Market, Regional Market Snapshot
13.2. North America Lymphedema Treatment Market
13.2.1. U.S. Lymphedema Treatment Market
13.2.1.1. Treatment Type breakdown estimates & forecasts, 2018-2027
13.2.1.2. Type breakdown estimates & forecasts, 2018-2027
13.2.1.3. Affected Area breakdown estimates & forecasts, 2018-2027
13.2.1.4. Age Group breakdown estimates & forecasts, 2018-2027
13.2.1.5. Route of Administration breakdown estimates & forecasts, 2018-2027
13.2.1.6. End User breakdown estimates & forecasts, 2018-2027
13.2.1.7. Distribution Channel breakdown estimates & forecasts, 2018-2027
13.2.2. Canada Lymphedema Treatment Market
13.3. Europe Lymphedema Treatment Market Snapshot
13.3.1. U.K. Lymphedema Treatment Market
13.3.2. Germany Lymphedema Treatment Market
13.3.3. France Lymphedema Treatment Market
13.3.4. Spain Lymphedema Treatment Market
13.3.5. Italy Lymphedema Treatment Market
13.3.6. Rest of Europe Lymphedema Treatment Market
13.4. Asia-Pacific Lymphedema Treatment Market Snapshot
13.4.1. China Lymphedema Treatment Market
13.4.2. India Lymphedema Treatment Market
13.4.3. Japan Lymphedema Treatment Market
13.4.4. Australia Lymphedema Treatment Market
13.4.5. South Korea Lymphedema Treatment Market
13.4.6. Rest of Asia Pacific Lymphedema Treatment Market
13.5. Latin America Lymphedema Treatment Market Snapshot
13.5.1. Brazil Lymphedema Treatment Market
13.5.2. Mexico Lymphedema Treatment Market
13.6. Rest of The World Lymphedema Treatment Market

Chapter 14. Competitive Intelligence
14.1. Top Market Strategies
14.2. Company Profiles
14.2.1. Paul Hartmann AG
14.2.1.1. Key Information
14.2.1.2. Overview
14.2.1.3. Financial (Subject to Data Availability)
14.2.1.4. Product Summary
14.2.1.5. Recent Developments
14.2.2. Convatec Inc.
14.2.3. SIGVARIS GROUP
14.2.4. Sanyleg Srl a socio unico
14.2.5. AIROS Medical, Inc.
14.2.6. Tactile Medical
14.2.7. BIOCOMPRESSION SYSTEMS
14.2.8. Lohmann & Rauscher GmbH & Co. KG
14.2.9. Mego Afek ltd.
14.2.10. ThermoTek, Cardinal Health
Chapter 15. Research Process
15.1. Research Process
15.1.1. Data Mining
15.1.2. Analysis
15.1.3. Market Estimation
15.1.4. Validation
15.1.5. Publishing
15.2. Research Attributes
15.3. Research Assumption